Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ono Pharma USA Inc
Age
18–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy male or female subjects, aged 18-64 inclusive
Body mass index (BMI) of 19-35 kg/m2 (inclusive)
IOP measurement oculus uterque (OU, both eyes) \< 21 mm Hg (inclusive) at screening and Day -1
Best corrected visual acuity (BCVA) 20/30 or better (Snellen Equivalent) at both the screening visit and Day -1
You may not be if
Any history of severe ocular trauma in either eye at any time
Any history of previous intraocular or ocular laser surgery within the past 3 months or any refractive surgery procedure within the past 6 months of the screening visit in either eye
Current or chronic history of ocular infection within the past 3 months of screening visit in either eye OR ongoing or recurrent ocular inflammation in either eye
At the ophthalmic investigator's discretion, any subjects who have a history of any significant ocular conditions in either eye that would contraindicate the use of the study medication, or that might affect the study conduct, or the interpretation of the study results
Use of any non-diagnostic topical ophthalmic solutions except for sponsor-recommended tear substitutes from admission to the study unit through the duration of the study
History of clinically significant drug or food allergy, positive HIV, hepatitis B or C at screening
